Cancer Research Annual Meeting 2010 Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuperwasser, C.
Right arrow Articles by Jerry, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuperwasser, C.
Right arrow Articles by Jerry, D. J.
[Cancer Research 60, 2723-2729, May 15, 2000]
© 2000 American Association for Cancer Research

Molecular Biology and Genetics

Cytoplasmic Sequestration and Functional Repression of p53 in the Mammary Epithelium Is Reversed by Hormonal Treatment1

Charlotte Kuperwasser, Jan Pinkas, Gregory D. Hurlbut, Stephen P. Naber and D. Joseph Jerry2

Program in Molecular and Cellular Biology [C. K., J. P., D. J. J.], and Department of Veterinary and Animal Sciences [G. D. H., D. J. J.], University of Massachusetts, Amherst, Massachusetts 01003, and Department of Pathology; Baystate Medical Center, Springfield, Massachusetts 01199 [S. P. N.]

Proper function of the p53 tumor suppressor gene is critical for inhibiting tumor development in a broad spectrum of tissues. Although the mammary gland is highly susceptible to tumor formation, the functional status of p53 in the normal tissue had not been investigated. Therefore, expression, localization, and activity of p53 were examined in normal mammary tissues. High levels of p53 protein were found expressed in the cytoplasm of the ductal epithelium of the quiescent mammary gland. Ionizing radiation failed to recruit p53 to the nucleus, and p53-dependent responses were minimal. However, transient hormonal stimulation resulted in nuclear accumulation of p53, an induction of p21/WAF1, and a 5-fold increase in apoptosis after ionizing radiation. Therefore, the functional state of wild-type p53 in the mammary epithelium can be regulated by hormonal stimuli.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. H. Shirley, J. E. Rundhaug, J. Tian, N. Cullinan-Ammann, I. Lambertz, C. J. Conti, and R. Fuchs-Young
Transcriptional Regulation of Estrogen Receptor-{alpha} by p53 in Human Breast Cancer Cells
Cancer Res., April 15, 2009; 69(8): 3405 - 3414.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Lu, K. A. Becker, M. J. Hagen, H. Yan, A. L. Roberts, L. A. Mathews, S. S. Schneider, H. T. Siegelmann, K. J. MacBeth, S. M. Tirrell, et al.
Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity
Endocrinology, October 1, 2008; 149(10): 4809 - 4820.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Bottger, E. Jerszyk, B. Low, and C. Walker
Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53
Cancer Res., February 1, 2008; 68(3): 777 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Sayeed, S. D. Konduri, W. Liu, S. Bansal, F. Li, and G. M. Das
Estrogen Receptor {alpha} Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis
Cancer Res., August 15, 2007; 67(16): 7746 - 7755.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
D. Medina
Mammary developmental fate and breast cancer risk
Endocr. Relat. Cancer, September 1, 2005; 12(3): 483 - 495.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Tu, D. J. Jerry, B. Pazik, and S. Smith Schneider
Sensitivity to DNA Damage Is a Common Component of Hormone-Based Strategies for Protection of the Mammary Gland
Mol. Cancer Res., August 1, 2005; 3(8): 435 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Meniel, T. Hay, A. Douglas-Jones, O. J. Sansom, and A. R. Clarke
Mutations in Apc and p53 Synergize to Promote Mammary Neoplasia
Cancer Res., January 15, 2005; 65(2): 410 - 416.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
L. M. Minter, E. S. Dickinson, S. P. Naber, and D. J. Jerry
Epithelial cell cycling predicts p53 responsiveness to {gamma}-irradiation during post-natal mammary gland development
Development, March 8, 2003; 129(12): 2997 - 3008.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H.-F. Yam, A. K.-H. Kwok, K.-P. Chan, T. Y.-Y. Lai, K.-Y. Chu, D. S.-C. Lam, and C. P. Pang
Effect of Indocyanine Green and Illumination on Gene Expression in Human Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 370 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. B. Ewan, R. L. Henshall-Powell, S. A. Ravani, M. J. Pajares, C. Arteaga, R. Warters, R. J. Akhurst, and M. H. Barcellos-Hoff
Transforming Growth Factor-{beta}1 Mediates Cellular Response to DNA Damage in Situ
Cancer Res., October 15, 2002; 62(20): 5627 - 5631.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. A. Stewart, W. C. Hahn, B. F. O'Connor, E. N. Banner, A. S. Lundberg, P. Modha, H. Mizuno, M. W. Brooks, M. Fleming, D. B. Zimonjic, et al.
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
PNAS, October 1, 2002; 99(20): 12606 - 12611.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Conway, S. N. Edmiston, L. Cui, S. S. Drouin, J. Pang, M. He, C.-K. Tse, J. Geradts, L. Dressler, E. T. Liu, et al.
Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer
Cancer Res., April 1, 2002; 62(7): 1987 - 1995.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
PNAS, October 12, 2001; (2001) 221459098.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Sengupta and B. Wasylyk
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2
Genes & Dev., September 15, 2001; 15(18): 2367 - 2380.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Ljungman
Individual Variation in p53 Responsiveness
J Natl Cancer Inst, January 17, 2001; 93(2): 82 - 83.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Kuperwasser, G. D. Hurlbut, F. S. Kittrell, E. S. Dickinson, R. Laucirica, D. Medina, S. P. Naber, and D. J. Jerry
Development of Spontaneous Mammary Tumors in BALB/c p53 Heterozygous Mice : A Model for Li-Fraumeni Syndrome
Am. J. Pathol., December 1, 2000; 157(6): 2151 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
PNAS, October 23, 2001; 98(22): 12379 - 12384.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.